StruXure Unveils Cabana X MOD at TimberTech Championship
At the charity tournament held
With the top 54 players from the 50-and-older circuit and over 700 volunteers on hand, the TimberTech Championship is more than a golf tournament. It's a way to benefit the Boca Raton Regional Hospital. TimberTech considers the Tournament a way to give back. For the second consecutive year, as a result of the Tournament, a
At last year's Tournament, StruXure unveiled Cabana X—its 4-posts, 4-beam, 17-louver smart cabana that is sturdy enough to stand up to harsh weather, yet simple enough to be considered a piece of outdoor furniture. This year at the TimberTech Championship, StruXure offered up its Cabana X MOD, the first modularly-designed cabana.
Cabana X MOD provides a way to customize your outdoor space. Begin with a single Cabana X and then decide if your space needs additional in-line or diagonal coverage, open-air or closed canopies, or a backdrop of privacy slats or panels or curtains. And while most consumers purchase Cabana X MOD with one location in mind, should you need to dismantle and move it, it's easy to do so.
About StruXure
StruXure is the premier designer and manufacturer of luxury pivoting-louver smart pergolas and cabanas. The company's mission is to change the way people live by bringing the indoors out through sustainable architectural automation and innovation. StruXure's products are made in the
Contact:
Phone: 310-614-7908
Email: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/struxure-unveils-cabana-x-mod-at-timbertech-championship-301994331.html
SOURCE StruXure
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Purina and Mariska Hargitay Bring the Purple Leash Project to U.S. Soccer, Launch Limited-Edition Scarves Supporting Abuse Survivors and Pets
- Cutaneous Lupus Erythematosus Therapeutics Market Size in the 7MM is projected to grow at a significant CAGR over the forecast period of 2026-2036 | DelveInsight
- First Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on Oct. 12, 2026
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share